J. J. Finkelstein - 17 May 2022 Form 4 Insider Report for REGENERX BIOPHARMACEUTICALS INC

Role
President and CEO, Director
Signature
/s/ Andrew Nick as Attorney-in-Fact for J.J. Finkelstein pursuant to Power of Attorney previously filed.
Issuer symbol
RGRX on OTC
Transactions as of
17 May 2022
Net transactions value
$0
Form type
4
Filing time
19 May 2022, 17:03:41 UTC
Previous filing
04 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RGRX Common Stock 1,712,991 17 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGRX Stock Option (Right to Buy) Award $0 +600,000 $0.000000 600,000 17 May 2022 Common Stock 600,000 $0.1900 Direct F4
holding RGRX Stock Option (right to buy) 500,000 17 May 2022 Common Stock 500,000 $0.3600 Direct F1
holding RGRX Stock Option (right to buy) 200,000 17 May 2022 Common Stock 200,000 $0.6400 Direct F1
holding RGRX Stock Option (right to buy) 150,000 17 May 2022 Common Stock 150,000 $0.2800 Direct F1
holding RGRX Stock Option (right to buy) 250,000 17 May 2022 Common Stock 250,000 $0.2100 Direct F1
holding RGRX Stock Option (right to buy) 650,000 17 May 2022 Common Stock 650,000 $0.2100 Direct F1
holding RGRX Stock Option (right to buy) 500,000 17 May 2022 Common Stock 500,000 $0.3000 Direct F2
holding RGRX Convertible Promissory Note (right to buy) 78,125 17 May 2022 Common Stock 104,167 $0.1200 Direct
holding RGRX Convertible Promissory Note (right to buy) 78,125 17 May 2022 Common Stock 104,167 $0.1200 Direct
holding RGRX Convertible Promissory Note (right to buy) 20,880 17 May 2022 Common Stock 27,840 $0.3600 Direct
holding RGRX Common Stock Warrant (right to buy) 56,250 17 May 2022 Common Stock 78,125 $0.1800 Direct
holding RGRX Common Stock Warrant (right to buy) 56,250 17 May 2022 Common Stock 78,125 $0.1800 Direct
holding RGRX Common Stock Warrant (right to buy) 0 17 May 2022 Common Stock 20,880 $0.4500 Direct
holding RGRX Series A Common Stock Warrant (right to buy) 0 17 May 2022 Common Stock 56,250 $0.2400 Direct
holding RGRX Series B Common Stock Warrant (right to buy) 0 17 May 2022 Common Stock 56,250 $0.2800 Direct
holding RGRX Stock Option (right to buy) 600,000 17 May 2022 Common Stock 600,000 $0.2800 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% vested.
F2 125,000 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23.
F3 150,000 shares vest on each of 8/2/21, 8/2/22, 8/2/23 and 8/2/24.
F4 150,000 shares vest on each of 5/17/22, 5/17/23, 5/17/24 and 5/17/25.